June 8 (Reuters) - Radius Health Inc RDUS.O :
* RADIUS HEALTH INC - ON JUNE 2, PROVIDED KINDEVA DRUG
DELIVERY,
L.P. WITH A WRITTEN NOTICE OF TERMINATION
* RADIUS HEALTH INC - NOTICE OF TERMINATION TO TERMINATE
SCALE-UP
AND COMMERCIAL SUPPLY AGREEMENT, DATED FEBRUARY 27, 2018 BY AND
BETWEEN CO AND KINDEVA
* RADIUS HEALTH - PROVIDED NOTICE OF TERMINATION AFTER CO
DECIDED
TO CEASE DEVELOPMENT AND COMMERCIALIZATION OF
ABALOPARATIDE-COATED TRANSDERMAL SYSTEM
* RADIUS HEALTH INC - TERMINATION SHALL BE EFFECTIVE ON JUNE
10,
2022
* RADIUS HEALTH INC - AS A RESULT OF TERMINATION OF
AGREEMENT,
COMPANY WILL NOT OWE KINDEVA ANY FACILITY FEES FOR MONTHS OF
MAY, JUNE OR JULY OF 2022
* RADIUS HEALTH - KINDEVA WILL NOT BEGIN PRODUCT THIRD-PARTY
CONTRACT MANUFACTURER FACILITY FEES IN JULY 2022, FOR WHICH CO
SHALL NOT OWE ANY PAYMENTS
Further company coverage: RDUS.O
((reuters.briefs@thomsonreuters.com;))